New implant could replace monthly shots for opioid addiction
Disease control
Not yet recruiting
This early-stage trial tests a new naltrexone implant (iSTEP-N) that slowly releases medication over 12 months to block opioids. It will enroll 33 healthy adults and compare two implant doses to standard monthly injections. The goal is to see if the implant can maintain steady dr…
Phase: PHASE1 • Sponsor: Akyso Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC